SCHEMBL9529216

SCHEMBL9529216

CSc1cccc2c1CCNC2CN1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 3/20 0.42
HTR7 P34969 3/20 0.42
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
OPRM1 P35372 2/20 0.34
ABCB1 P08183 2/20 0.33
PRCP P42785 1/20 0.33
CHRNA7 P36544 1/20 0.32
PARP1 P09874 1/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532270 0.83 OPRL1 (0.41) OPRM1ABCB1PRCPPARP1
SCHEMBL9530729 0.80 HTR2C (0.43) HTR2AHTR2CHTR2BOPRM1CHRNA7
SCHEMBL9529309 0.80 OPRD1 (0.46) OPRM1HTR1A
SCHEMBL9527933 0.80 HTR7 (0.38) HTR7HTR2AHTR2COPRM1ABCB1
SCHEMBL9529211 0.80 SIGMAR1 (0.48) CHRNA7HTR1A
Bromide SCHEMBL9529783 0.79 OPRD1 (0.45) OPRM1HTR1A
SCHEMBL9530051 0.79 SIGMAR1 (0.50) CHRM4ABCB1CHRNA7HTR1A
Bromide SCHEMBL9532399 0.78 OPRD1 (0.44) OPRM1HTR1A
Bromide SCHEMBL9531812 0.75 ADRA2A (0.37)
Acetic Acid SCHEMBL9530466 0.74 MAPKAPK2 (0.46) OPRM1CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0330360-B1 1,2,3,4-Tetrahydroisoquinolines, processes for their preparation, and their use as kappa-receptor agonists SMITHKLINE BEECHAM FARMA (IT) 1993-12-01 EP disclosed
US-4954509-A Isoquinoline derivatives and their use as analgesics DR. LO. ZAMBELETTI S.P.A. (IT) 1990-09-04 US disclosed
EP-0330360-A1 1,2,3,4-Tetrahydroisoquinolines, processes for their preparation, and their use as kappa-receptor agonists SmithKline Beecham Farmaceutici S.p.A. (IT) 1989-08-30 EP disclosed